Quick wins for a faster PC:
Clear out junk files and repair common Windows errorsFree Scan →Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
Adding antibiotics can change PMMA bone cement’s porosity, antibiotic release, and strength, but the direction and size of the effects depend on the cement, antibiotic dose and form, specimen geometry, and mixing process. In a 2026 in vitro comparison using vancomycin in high-viscosity Palacos R, liquid incorporation produced greater porosity, while powdered vancomycin produced greater cumulative release from beads. Higher vancomycin loading was associated with lower compressive and bending strength in both groups.
What porosity changes—and what it does not tell you
Porosity describes the void space within a material. In antibiotic-loaded PMMA cement, it matters in part because pores can increase the surface exposed to surrounding fluid and influence how an antibiotic elutes, or is released from the cement. But porosity is not a substitute for measuring release: antibiotic proportion, cement formulation, specimen geometry, and preparation can also affect the amount and time course of release.
That distinction is central to interpreting comparative results. A formulation can have more measured porosity without delivering more antibiotic over a specified period. Release, porosity, and mechanical strength are separate outcomes, and a result for one does not establish the result for another.
What the 2026 vancomycin comparison found
Loh et al. (2026) compared powdered vancomycin with vancomycin dissolved in water and incorporated into high-viscosity Palacos R. The tested loading range was 1–4 g vancomycin per 40 g cement. The study measured vancomycin release over six weeks and evaluated porosity and mechanical properties in laboratory specimens; it was not a patient-outcome study.
#1 Best Overall
| Outcome | Powdered vancomycin | Vancomycin dissolved in water | How to interpret the comparison |
|---|---|---|---|
| Porosity | Lower than the liquid-incorporated group in this comparison | Greater than the powdered group in this comparison | The result is specific to the tested Palacos R formulation and preparation. |
| Cumulative release from beads | Greater than the liquid-incorporated group | Lower than the powdered group | The study measured release over six weeks; higher porosity did not correspond to greater cumulative bead release in this comparison. |
| Compressive and bending strength | Both declined as vancomycin loading increased | Both declined as vancomycin loading increased | The reported relationship was dose-dependent in both incorporation groups; the available results do not establish a general percentage loss. |
The key finding is not that one incorporation method is best overall. The liquid group had greater porosity, but powder-mixed beads had greater cumulative release. Those outcomes point in different directions, while the strength results add a separate trade-off: higher loading was associated with weaker cement in both groups. The study does not establish that greater porosity always improves release or that either method is preferable for every clinical use.
Why results differ between cement studies
Comparisons are meaningful only when the formulation and test setup are taken into account. A clinical-use review identifies cement brand and type, antibiotic choice and proportion, specimen geometry, homogenization, and vacuum mixing as factors that can influence elution and material properties. It also notes conflicting effects of vacuum mixing on elution across commercial cements.
A 2020 ACS study likewise reports that PMMA processing affects porosity and downstream properties. In that study, vacuum mixing improved mechanical strength but produced less homogeneity than hand mixing. This is a study-specific observation, not a universal ranking of mixing methods. Mixing belongs in the description of the formulation because it can affect the material being tested.
Align these variables before comparing two results
- Antibiotic: identity, physical form, and amount relative to the cement.
- Base cement: brand, type, and formulation.
- Preparation: hand or vacuum mixing and the homogenization process.
- Specimen: shape and geometry, which affect exposed surface area.
- Endpoint: porosity, release amount and time course, compressive strength, or bending strength.
If these differ, an apparent disagreement between studies may reflect the tested setup rather than a contradiction about a single universal property of antibiotic-loaded PMMA.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.What the evidence means for clinical interpretation
The 2026 results are in vitro findings for one cement type and vancomycin formulations. Bead, cylinder, and block measurements are laboratory specimen results, not evidence of outcomes in patients. They do not prove clinical effectiveness, identify an optimal spacer formulation, or support transferring the same effect to another antibiotic, cement, or surgical application.
For a cement intended to release antibiotic, porosity is only one consideration. Any potential release benefit must be weighed against mechanical properties and the cement’s intended role. The reported dose-related reductions in compressive and bending strength make loading an important part of that balance, but the evidence here does not supply a universal safe or optimal dose.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
